Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTEST CORP
Report date March 31, 2026 · Filed April 02, 2026
Section 16 reporting ended · disclosed 2026-04-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 110,923 |
Ending reported balance
After 2026-03-31 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2026-03-31 · Disposition to issuer · Disposed 2,465 · Balance 210,265 F1: Unvested shares forfeited related to Mr. Grant's March 8, 2023 time-vesting restricted stock award. Row 2 · 2026-03-31 · Disposition to issuer · Disposed 8,826 · Balance 201,439 F2: Unvested shares forfeited related to Mr. Grant's March 6, 2024 time-vesting restricted stock award. Row 3 · 2026-03-31 · Disposition to issuer · Disposed 17,652 · Balance 183,787 F3: Unvested shares forfeited related to Mr. Grant's March 6, 2024 performance-vesting restricted stock award. Row 4 · 2026-03-31 · Disposition to issuer · Disposed 19,380 · Balance 164,407 F4: Unvested shares forfeited related to Mr. Grant's March 17, 2025 time-vesting restricted stock award. Row 5 · 2026-03-31 · Disposition to issuer · Disposed 25,840 · Balance 138,567 F5: Unvested shares forfeited related to Mr. Grant's March 17, 2025 performance-vesting restricted stock award. Row 6 · 2026-03-31 · Disposition to issuer · Disposed 13,822 · Balance 124,745 F6: Unvested shares forfeited related to Mr. Grant's March 16, 2026 time-vesting restricted stock award. Row 7 · 2026-03-31 · Disposition to issuer · Disposed 13,822 · Balance 110,923 F7: Unvested shares forfeited related to Mr. Grant's March 16, 2026 performance-vesting restricted stock award. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.74 · Expires 2035-03-16 | Direct | 581 |
Reported balance
Holding disclosure · report date 2026-03-31 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 581 F8: This option is fully exercisable as of the date of this report. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.74 · Expires 2035-03-16 | Direct | 10,846 |
Reported balance
Holding disclosure · report date 2026-03-31 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 10,846 F8: This option is fully exercisable as of the date of this report. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.33 · Expires 2034-03-05 | Direct | 15,268 |
Reported balance
Holding disclosure · report date 2026-03-31 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 15,268 F8: This option is fully exercisable as of the date of this report. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.06 · Expires 2033-03-07 | Direct | 12,741 |
Reported balance
Holding disclosure · report date 2026-03-31 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 12,741 F8: This option is fully exercisable as of the date of this report. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.76 · Expires 2032-03-08 | Direct | 25,692 |
Reported balance
Holding disclosure · report date 2026-03-31 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 25,692 F8: This option is fully exercisable as of the date of this report. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.62 · Expires 2031-03-09 | Direct | 112,000 |
Reported balance
Holding disclosure · report date 2026-03-31 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 112,000 F8: This option is fully exercisable as of the date of this report. |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested shares forfeited related to Mr. Grant's March 8, 2023 time-vesting restricted stock award.
F2: Unvested shares forfeited related to Mr. Grant's March 6, 2024 time-vesting restricted stock award.
F3: Unvested shares forfeited related to Mr. Grant's March 6, 2024 performance-vesting restricted stock award.
F4: Unvested shares forfeited related to Mr. Grant's March 17, 2025 time-vesting restricted stock award.
F5: Unvested shares forfeited related to Mr. Grant's March 17, 2025 performance-vesting restricted stock award.
F6: Unvested shares forfeited related to Mr. Grant's March 16, 2026 time-vesting restricted stock award.
F7: Unvested shares forfeited related to Mr. Grant's March 16, 2026 performance-vesting restricted stock award.
F8: This option is fully exercisable as of the date of this report.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2026 Filed Apr 2, 2026 20:52 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 13,822 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000114 · form4.xml · nonDerivative · entry 7 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,923 F7 · shares: Unvested shares forfeited related to Mr. Grant's March 16, 2026 performance-vesting restricted stock award. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:52 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 13,822 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000114 · form4.xml · nonDerivative · entry 6 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,745 F6 · shares: Unvested shares forfeited related to Mr. Grant's March 16, 2026 time-vesting restricted stock award. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:52 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 25,840 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000114 · form4.xml · nonDerivative · entry 5 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,567 F5 · shares: Unvested shares forfeited related to Mr. Grant's March 17, 2025 performance-vesting restricted stock award. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:52 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 19,380 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000114 · form4.xml · nonDerivative · entry 4 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,407 F4 · shares: Unvested shares forfeited related to Mr. Grant's March 17, 2025 time-vesting restricted stock award. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:52 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 17,652 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000114 · form4.xml · nonDerivative · entry 3 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,787 F3 · shares: Unvested shares forfeited related to Mr. Grant's March 6, 2024 performance-vesting restricted stock award. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:52 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 8,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000114 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,439 F2 · shares: Unvested shares forfeited related to Mr. Grant's March 6, 2024 time-vesting restricted stock award. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:52 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 2,465 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000114 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,265 F1 · shares: Unvested shares forfeited related to Mr. Grant's March 8, 2023 time-vesting restricted stock award. Read SEC document |
| March 18, 2026 Filed Mar 18, 2026 21:02 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 1,636 | $14.28 | $23,360.44 |
DisclosureSEC source: 0000891839-26-000095 · form4.xml · nonDerivative · entry 3 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 212,730 F3 · kind: Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.25 to $14.425, inclusive. The reporting person undertakes to provide InTest Corporation, any security holder of InTest Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:02 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 23,365 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0000891839-26-000095 · form4.xml · derivative · entry 4 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,365 Underlying: Common Stock · 23,365 shares Expires 2036-03-15 F5 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:02 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 13,822 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000095 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,366 F2 · shares: These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in March 2029 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 20,733. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:02 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 13,822 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000095 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,544 F1 · shares: These restricted shares were granted pursuant to the InTest Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027. Read SEC document |
| March 11, 2026 Filed Mar 11, 2026 20:30 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 1,397 | $14.16 | $19,786.97 |
DisclosureSEC source: 0000891839-26-000079 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,722 F1 · kind: Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:30 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 1,097 | $13.33 | $14,618.51 |
DisclosureSEC source: 0000891839-26-000079 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,119 F1 · kind: Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:29 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 9,859 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000069 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,216 F1 · shares: Shares forfeited under the terms of Mr. Grant's performance-based restricted stock award granted on March 8, 2023. Read SEC document |
| April 14, 2025 Filed Apr 14, 2025 20:30 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 13,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-007443 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,075 F1 · shares: Shares forfeited under the terms of Mr. Grant's performance-based restricted stock award granted on March 9, 2022. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:35 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 43,384 | $0.00 Strike: $7.74 | $0.00 |
DisclosureSEC source: 0001062993-25-005902 · form4.xml · derivative · entry 4 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,384 Underlying: Common Stock · 43,384 shares Expires 2035-03-16 F4 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:35 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 2,327 | $4.61 Strike: $7.74 | $10,727.47 |
DisclosureSEC source: 0001062993-25-005902 · form4.xml · derivative · entry 3 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,327 Underlying: Common Stock · 2,327 shares Expires 2035-03-16 F3 · price: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 in lieu of an annual base salary merit increase of $10,723. This option will vest in four equal annual installments commencing on March 17, 2026. F3 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 in lieu of an annual base salary merit increase of $10,723. This option will vest in four equal annual installments commencing on March 17, 2026. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:35 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 25,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005902 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,737 F2 · shares: These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 17, 2028 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 38,760. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:35 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 25,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005902 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,897 F1 · shares: These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 21:37 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 1,184 | $7.57 | $8,962.88 |
DisclosureSEC source: 0001062993-25-005271 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 161,057 F1 · kind: Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $7.60, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 21:37 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 2,688 | $7.48 | $20,106.24 |
DisclosureSEC source: 0001062993-25-005271 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,241 F1 · kind: Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.35 to $7.52, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 27, 2024 Filed Aug 27, 2024 20:31 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 6,788 | $6.97 | $47,312.36 |
DisclosureSEC source: 0001062993-24-015747 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,929 F1 · kind: Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.90 to $7.08, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 11, 2024 Filed Apr 11, 2024 21:34 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 21,500 | $12.03 | $258,645.00 |
DisclosureSEC source: 0001062993-24-008309 · form4.xml · nonDerivative · entry 3 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,717 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.91 to $12.20, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2024 Filed Apr 11, 2024 21:34 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 22,000 | $12.03 | $264,660.00 |
DisclosureSEC source: 0001062993-24-008309 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 193,217 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.83 to $12.56, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2024 Filed Apr 11, 2024 21:34 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 20,000 | $12.80 | $256,000.00 |
DisclosureSEC source: 0001062993-24-008309 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,217 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.46 to $13.23, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 20:30 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 1,167 | $11.16 | $13,023.72 |
DisclosureSEC source: 0001062993-24-006276 · form4.xml · nonDerivative · entry 3 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,217 F1 · shares: These shares were withheld to cover tax withholding obligations on the vesting of restricted stock. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 20:30 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 854 | $11.16 | $9,530.64 |
DisclosureSEC source: 0001062993-24-006276 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,384 F1 · shares: These shares were withheld to cover tax withholding obligations on the vesting of restricted stock. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:30 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 617 | $11.16 | $6,885.72 |
DisclosureSEC source: 0001062993-24-006276 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,238 F1 · shares: These shares were withheld to cover tax withholding obligations on the vesting of restricted stock. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:30 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 30,536 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001062993-24-005986 · form4.xml · derivative · entry 3 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,536 Underlying: Common Stock · 30,536 shares Expires 2034-03-05 F3 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:30 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 17,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005986 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,855 F2 · shares: These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 6, 2027 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 26,478. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:30 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 17,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005986 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,203 F1 · shares: These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025. Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 20:32 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 4,153 | $16.44 | $68,275.32 |
DisclosureSEC source: 0001062993-23-017167 · form4.xml · nonDerivative · entry 3 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,551 F3 · shares: These shares were withheld to cover tax withholding obligations upon the vesting of a time-based restricted stock award. Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 20:32 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 30,859 | $16.44 | $507,321.96 |
DisclosureSEC source: 0001062993-23-017167 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,704 F2 · shares: These shares were withheld to cover tax withholding obligations upon the vesting of a performance-based restricted stock award. Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 20:32 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 37,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017167 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,563 F1 · shares: These shares were awarded to Mr. Grant upon the vesting of a performance-based restricted stock award granted to him under the Issuer's Third Amended and Restated 2014 Stock Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:29 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 1,167 | $15.98 | $18,648.66 |
DisclosureSEC source: 0001062993-23-006830 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,982 F1 · shares: Shares withheld to cover tax withholding obligations on the vesting of restricted stock. Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 21:37 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 854 | $16.44 | $14,039.76 |
DisclosureSEC source: 0001062993-23-006629 · form4.xml · nonDerivative · entry 3 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,149 F3 · shares: Shares withheld to cover tax withholding obligations on the vesting of restricted stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:37 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 16,988 | $0.00 Strike: $16.06 | $0.00 |
DisclosureSEC source: 0001062993-23-006629 · form4.xml · derivative · entry 4 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,988 Underlying: Common Stock · 16,988 shares Expires 2033-03-07 F4 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:37 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 9,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006629 · form4.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,003 F2 · shares: These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 8, 2026 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 14,789. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:37 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 9,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006629 · form4.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,144 F1 · shares: These restricted shares were granted pursuant to the Issuer's Fourth Amended and Restated 2014 Stock Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 18:28 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 4,153 | $9.26 | $38,450.55 |
DisclosureSEC source: 0001036262-22-000014 · primary_doc.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,284 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F2 · price: The price reported is the weighted average sale price of the shares sold in multiple transactions at prices ranging from $9.16 to $9.27, inclusive. Upon request, the reporting person will provide to the SEC, the issuer, or any security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 19:35 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 1,167 | $9.50 | $11,086.50 |
DisclosureSEC source: 0001036262-22-000005 · primary_doc.xml · nonDerivative · entry 3 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,437 F3 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 19:35 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 25,692 | $0.00 Strike: $9.76 | $0.00 |
DisclosureSEC source: 0001036262-22-000005 · primary_doc.xml · derivative · entry 4 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,692 Underlying: Common Stock · 25,692 shares Expires 2032-03-08 F4 · derivative.exercise_date: The option was issued pursuant to the Plan and will vest 25% annually commencing on March 9, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 19:35 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 13,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-22-000005 · primary_doc.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,604 F2 · shares: The shares acquired are performance-based restricted shares issued pursuant to the Plan and will vest on March 9, 2025 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 20,493. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 19:35 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 13,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-22-000005 · primary_doc.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,942 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan (the "Plan") and will vest 25% annually commencing on March 9, 2023. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 18:05 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 112,000 | $0.00 Strike: $10.62 | $0.00 |
DisclosureSEC source: 0001036262-21-000005 · primary_doc.xml · derivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: Common Stock · 112,000 shares Expires 2031-03-09 F2 · derivative.exercise_date: The option vests in four equal installments beginning on March 10, 2022. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 18:05 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 18,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-21-000005 · primary_doc.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,278 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan and will vest 25% annually commencing on March 10, 2022. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 16:14 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 75,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-20-000012 · primary_doc.xml · nonDerivative · entry 2 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,610 F2 · shares: The shares acquired are performance-based restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan, that will vest on August 24, 2023 dependent upon certain performance criteria. The amount shown reflects the number of share that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 112,743. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 16:14 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 66,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-20-000012 · primary_doc.xml · nonDerivative · entry 1 Grant Richard N. Jr. · CIK 0001821315 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,448 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan and will vest 25% annually commencing on August 24, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.